News
Lululemon (LULU) Tops Q4 Earnings and Revenue Estimates
Lululemon (LULU) came out with quarterly earnings of $5.01 per share, beating the Zacks Consensus Estimate of $4.76 per share. This compares to earnings of $6.14 per share a year ago. These figures
Energy Vault Holdings, Inc. (NRGV) Reports Q4 Loss, Tops Revenue Estimates
Energy Vault Holdings, Inc. (NRGV) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.35 per share a year ago
DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
DocuSign (DOCU) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.86 per share a year ago. These figures
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.69 per share a year ago. These
Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates
Gossamer Bio (GOSS) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.15 per share a year ago. These figures are
Why Credo and Astera Soared After Oracle and Broadcom's Earnings
Credo Technology (NASDAQ: CRDO) and Astera Labs (NASDAQ: ALAB) are some of the fastest-growing beneficiaries of the artificial intelligence (AI) data center buildout.
As key suppliers in the data
Micron Continues to Display The Power of the Zacks Rank
Micron MU is a world leader in innovative memory and storage solutions that accelerate the transformation of information into intelligence. Shares have been red hot on the back of the AI frenzy
NVIDIA Rally? The Market Hasn’t Seen Anything Yet
If you think that NVIDIA’s (NASDAQ: NVDA) rally-to-date has been impressive, just wait for what comes next. News revealed at the GTC developer conference shows the AI boom is still growing, much
Top Stock Reports for GE Aerospace, Shell & McKesson
Tuesday, March 17, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including GE Aerospace
Rubrik’s Selloff Could Be Cybersecurity’s Hidden Opportunity
Rubrik (NYSE: RBRK) is a different kind of cybersecurity company, generating impressive growth as customers recognize the value of its differentiated approach. Most cybersecurity companies focus
Howmet's Defense Aerospace Strength Seems Firm: More Upside Ahead?
Howmet Aerospace Inc. HWM is poised to gain from the expanding defense budget, which remains a key growth catalyst. In the fourth quarter of 2025, revenues from the defense aerospace market rose 20%
CSCO Taps NVIDIA to Drive Secure AI at the Edge: More Upside Ahead?
Cisco Systems CSCO is expanding its Secure AI Factory with NVIDIA Corporation (NVDA), which will enable enterprises to run AI everywhere instead of only in large data centers. The expanded solution
AIG Expands Specialty Reach With McGill Tie-Up, Targets $1.6B Book
American International Group, Inc. AIG recently entered into a long-term strategic partnership with McGill and Partners. The goal is to modernize specialty insurance using data and digital tools
Best Value Stocks to Buy Now and How to Find Them
No one knows what’s right around the corner given the geopolitical turmoil. Still, stocks jumped slightly through morning trading on Tuesday after the Nasdaq and the S&P 500 charged higher to start
Palantir’s New Partnership Continues Separating Fact From Fiction
There are several headlines that are taking a backseat to more pressing geopolitical concerns. However, the announcement that Palantir Technologies (NASDAQ: PLTR) and NVIDIA (NASDAQ: NVDA) are
The New Threat IBM's Quantum Computing Research Poses to D-Wave
In the race to achieve quantum computing supremacy, a pure-play firm like D-Wave Quantum Inc. (NYSE: QBTS) must watch out for not only competitors of a similar size and scope but also for much
FEIM's Q3 Earnings Down Y/Y Due to Margin Pressure, Backlog Grows
Shares of Frequency Electronics, Inc. FEIM have declined 11.4% since the company reported its earnings for the quarter ended Jan. 31, 2026, underperforming the S&P 500 index, which fell 2.1% over
NU's Post-Earnings Dip Despite Strong Results: A Buying Opportunity?
Sometimes it helps to step back after results are out and let the market digest the numbers before concluding. Following its late-February earnings release, Nu Holdings NU saw its stock slide
Tredegar's Q4 Earnings Soar Y/Y on Aluminum Extrusions Strength
Shares of Tredegar Corporation TG have underperformed the broader market following the release of its fourth-quarter results. The stock has declined 3.4% since the earnings announcement for the
Best Momentum Stocks on the Zacks Rank (CIEN, MU, CENX)
There is always a bull market somewhere.
Despite shifting headlines and constantly evolving market narratives, certain stocks and sectors continue to benefit from prevailing economic regimes. In the
RGA Offers Upside on Strong Growth Prospects - Buy or Hold the Stock?
Reinsurance Group of America RGA is a leading global provider of traditional life and health reinsurance, as well as financial solutions, with operations across the United States, Latin America
KROS: Is the Discount Book Value a Value Trap?
Keros Therapeutics KROS posted a dramatic revenue jump in 2025, but the mix matters as much as the magnitude. The shares also trade at a steep discount to book value, creating the classic biotech
KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
Keros Therapeutics KROS enters 2026 with a clearer catalyst stack and a tighter operational focus. The near-term setup is led by rinvatercept, with study starts and regulatory interactions now
KROS Stock: What to Know About Rinvatercept in DMD
Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular dystrophy at the front of the line. The company is positioning the program


